Skip to main content

Find Clinical Trials

Home
Conditions
Human Immunodeficiency Virus

Clinical trial condition

Human Immunodeficiency Virus

Explore clinical trials studying Human Immunodeficiency Virus. Study availability and eligibility vary by location and protocol.

279 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Human Immunodeficiency Virus trial results

Completed

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

NCT00648999

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Site Ref # / Investigator 4074 León, Guanajauto, Mexico

Site Ref # / Investigator 4049 Mexico City, Mexico

Site Ref # / Investigator 4050 Mexico City, Mexico

Site Ref # / Investigator 4051 Mexico City, Mexico

View all 13 locations

View Trial Details

Completed

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

NCT01289951

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Hospital Universitario Ramón y Cajal. Madrid, Spain

View Trial Details

Completed

Kaletra: Therapy With Double Protease Inhibitors

NCT01075191

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Site Reference ID/Investigator# 48283 Berlin, Germany

Site Reference ID/Investigator# 28131 Berlin, Germany

Site Reference ID/Investigator# 66422 Berlin, Germany

Site Reference ID/Investigator# 28123 Berlin, Germany

View all 17 locations

View Trial Details

Completed

Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir

NCT00458302

Conditions: AIDS Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus, +16 more
Locations: Vienna, Austria

Antwerp, Belgium

Brussels, Belgium

Aarhus, Denmark

View all 27 locations

View Trial Details

Completed

Computer-Assisted Tailored Cue-card Health [CATCH] Study

NCT01170741

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
Locations: RTI International - Wake County Field Site Raleigh, North Carolina, United States

View Trial Details

Completed

Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

NCT01348516

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Clinical Trials Center, Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression

NCT01613157

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Maple Leaf Medical Clinic Toronto, Ontario, Canada

View Trial Details

Completed

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

NCT00333736

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +20 more
Locations: Maple Leaf Medical Clinic Toronto, Ontario, Canada

View Trial Details

Completed

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

NCT00333684

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: Maple Leaf Medical Clinic Toronto, Ontario, Canada

View Trial Details

Completed

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

NCT00333892

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details